"Antibiotic" isn't one thing — it's a label for dozens of chemically unrelated drug families that happen to share one property: they kill or suppress bacteria. Knowing how a drug does that — which bacterial target it hits, whether it kills outright or just holds the population down, and how wide a net it casts — is what lets you reason about empirical choice, allergy cross-reactivity, and combination therapy instead of just pattern-matching drug names. This page organises antibiotics the three ways they're most commonly classified in practice, with links through to a weight-based dose calculator for every class ClinixCal currently covers.
1. Classification by mechanism of action
This is the classification that actually predicts drug behaviour — it groups antibiotics by which bacterial structure or process they disrupt.
| Target | Mechanism | Example classes |
|---|---|---|
| Cell wall | Inhibit peptidoglycan cross-linking, causing osmotic lysis | Penicillins, cephalosporins, carbapenems, glycopeptides |
| Protein synthesis (30S ribosome) | Block the small ribosomal subunit, causing misreading or stalled initiation | Aminoglycosides, tetracyclines |
| Protein synthesis (50S ribosome) | Block peptide bond formation or chain elongation at the large subunit | Macrolides, lincosamides, oxazolidinones |
| Nucleic acid synthesis | Inhibit DNA gyrase/topoisomerase IV or RNA polymerase | Fluoroquinolones, rifamycins, nitroimidazoles |
| Folate pathway | Block sequential steps of bacterial folate synthesis, starving nucleotide production | Sulfonamides + trimethoprim |
| Cell membrane / other | Disrupt membrane integrity or a unique metabolic step | Fosfomycin (cell wall precursor synthesis) |
2. Classification by chemical class
This is the classification you'll see most on a hospital antibiogram or in a prescribing reference — it's the basis for cross-allergy reasoning (e.g. penicillin allergy and cephalosporin cross-reactivity) and for how resistance mechanisms are typically described.
| Class | Subtype | ClinixCal calculators |
|---|---|---|
| Beta-lactams | Penicillins | Amoxicillin, Amoxicillin-Clavulanate, Ampicillin, Cloxacillin, Piperacillin-Tazobactam |
| Cephalosporins | Cephalexin (1st-gen), Cefuroxime (2nd-gen), Cefixime, Cefpodoxime, Cefotaxime, Ceftriaxone, Ceftazidime (3rd-gen) | |
| Carbapenems | Meropenem, Meropenem Renal Adjustment | |
| Monobactams | Not yet on ClinixCal — suggest one | |
| Glycopeptides | — | Vancomycin |
| Aminoglycosides | — | Amikacin, Gentamicin |
| Macrolides | — | Azithromycin, Clarithromycin, Erythromycin |
| Lincosamides | — | Clindamycin |
| Tetracyclines | — | Doxycycline |
| Fluoroquinolones | — | Ciprofloxacin, Levofloxacin |
| Nitroimidazoles | — | Metronidazole, Tinidazole |
| Sulfonamide combinations | — | Co-trimoxazole (TMP-SMX) |
| Oxazolidinones | — | Linezolid |
| Rifamycins | — | Rifampicin |
| Phosphonic acid derivatives | — | Nitrofurantoin*, Fosfomycin |
*Nitrofurantoin is technically its own nitrofuran class, grouped here alongside fosfomycin only because both are UTI-specific oral agents with unrelated but narrowly-targeted mechanisms.
3. Classification by spectrum of activity
"Spectrum" describes how many different bacterial species a drug is active against — narrower isn't worse; it's usually the more stewardship-conscious choice once a specific organism is known.
- Narrow-spectrum — active against a limited range of organisms, e.g. cloxacillin (staphylococci), vancomycin (Gram-positives including MRSA).
- Broad-spectrum — active against a wide range of Gram-positive and Gram-negative organisms, e.g. piperacillin-tazobactam, meropenem, ciprofloxacin. Reserved for empirical therapy in severe or polymicrobial infection, then de-escalated once culture results are back.
- Extended-spectrum — a narrower agent modified (or combined with a beta-lactamase inhibitor) to cover additional organisms, e.g. amoxicillin extended to amoxicillin-clavulanate for beta-lactamase-producing strains.
4. Bactericidal vs bacteriostatic
A second, independent axis: does the drug kill bacteria outright, or just stop them multiplying so the host immune system can clear the rest?
| Bactericidal (kills) | Bacteriostatic (inhibits growth) | |
|---|---|---|
| Typical classes | Beta-lactams, aminoglycosides, fluoroquinolones, glycopeptides, metronidazole | Macrolides, tetracyclines, clindamycin, linezolid, sulfonamides |
| Relies on host immunity to finish clearance? | Less so | More so |
| Preferred when | Immunocompromised host, endocarditis, meningitis — situations needing rapid, immune-independent killing | Immunocompetent host with a less critical infection |
This distinction isn't absolute — some drugs are bactericidal against certain organisms and bacteriostatic against others (e.g. linezolid is bactericidal against streptococci but bacteriostatic against staphylococci) — but it remains a useful first-pass framework, especially for choosing therapy in immunocompromised patients or deep-seated infections like endocarditis.
Why classification matters clinically
- Predicting cross-allergy — a documented penicillin allergy raises the pre-test probability of a cephalosporin reaction (though true cross-reactivity is lower than historically taught, and generation-dependent).
- Combination therapy logic — combining a cell-wall-active agent (e.g. a penicillin) with a protein-synthesis inhibitor can be synergistic, since wall damage improves the second drug's intracellular access — the classic rationale behind ampicillin + gentamicin in endocarditis.
- Avoiding antagonism — pairing a bactericidal cell-wall agent with a bacteriostatic protein-synthesis inhibitor can, in some contexts, blunt the bactericidal drug's effect, since it needs actively dividing bacteria to work.
- Antibiotic stewardship — recognising which drugs are broad vs narrow-spectrum is the basis of empirical-then-de-escalate prescribing, which limits selection pressure for resistance.
Browse the full list of weight-based tools on the Antibiotics calculator page, or see where this fits in ClinixCal's wider Antimicrobial category (Antifungal and Antiviral sub-categories are in progress).
Frequently asked questions
What are the main ways antibiotics are classified?
Three main ways: by mechanism of action (which bacterial process they disrupt — cell wall, protein synthesis, nucleic acid synthesis, or folate synthesis), by chemical class (e.g. penicillins, cephalosporins, macrolides, fluoroquinolones), and by spectrum of activity (narrow vs broad). A fourth axis, bactericidal vs bacteriostatic, is also commonly used alongside these.
What is the difference between bactericidal and bacteriostatic antibiotics?
Bactericidal antibiotics (e.g. penicillins, aminoglycosides, fluoroquinolones) actively kill bacteria. Bacteriostatic antibiotics (e.g. macrolides, tetracyclines, clindamycin) only stop bacterial replication, relying on the host immune system to clear the remaining organisms. Bactericidal agents are generally preferred in immunocompromised patients or deep infections like endocarditis and meningitis.
What are beta-lactam antibiotics?
Beta-lactams are a chemical class sharing a four-membered beta-lactam ring, which inhibits bacterial cell wall (peptidoglycan) synthesis. The group includes penicillins, cephalosporins, carbapenems, and monobactams — all bactericidal, and all sharing some degree of cross-allergy risk within and between subgroups.
What is the difference between narrow-spectrum and broad-spectrum antibiotics?
Narrow-spectrum antibiotics act against a limited range of bacterial species (e.g. cloxacillin against staphylococci), while broad-spectrum antibiotics cover a wide range of Gram-positive and Gram-negative organisms (e.g. meropenem, piperacillin-tazobactam). Broad-spectrum agents are typically reserved for empirical therapy in severe infection and then de-escalated once culture and sensitivity results are available, as part of antibiotic stewardship.
Why does antibiotic classification matter for prescribing?
It predicts allergy cross-reactivity, guides rational combination therapy (avoiding antagonistic pairings of bactericidal and bacteriostatic agents), and underpins stewardship practice — choosing the narrowest effective agent to limit resistance pressure.
References
- Kapoor G, Saigal S, Elongavan A. Action and resistance mechanisms of antibiotics: A guide for clinicians. J Anaesthesiol Clin Pharmacol. 2017;33(3):300-305.
- Etebu E, Arikekpar I. Antibiotics: Classification and mechanisms of action with emphasis on molecular perspectives. Int J Appl Microbiol Biotechnol Res. 2016;4:90-101.
- British National Formulary for Children (BNFC) — Antibacterial drugs, class overviews.
- WHO Model List of Essential Medicines — Anti-infective medicines section.